Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 309

1.

Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency.

Finkenstedt A, Bianchi P, Theurl I, Vogel W, Witcher DR, Wroblewski VJ, Murphy AT, Zanella A, Zoller H.

Br J Haematol. 2009 Mar;144(5):789-93. doi: 10.1111/j.1365-2141.2008.07535.x. Epub 2008 Dec 20.

PMID:
19120353
2.

Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia.

Theurl I, Finkenstedt A, Schroll A, Nairz M, Sonnweber T, Bellmann-Weiler R, Theurl M, Seifert M, Wroblewski VJ, Murphy AT, Witcher D, Zoller H, Weiss G.

Br J Haematol. 2010 Feb;148(3):449-55. doi: 10.1111/j.1365-2141.2009.07961.x. Epub 2009 Oct 15.

PMID:
19863534
3.

Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II.

Casanovas G, Swinkels DW, Altamura S, Schwarz K, Laarakkers CM, Gross HJ, Wiesneth M, Heimpel H, Muckenthaler MU.

J Mol Med (Berl). 2011 Aug;89(8):811-6. doi: 10.1007/s00109-011-0751-5. Epub 2011 Apr 8.

PMID:
21475976
4.

[Effect of GDF15 on iron overloading and erythropoiesis].

Zhao YS, Chang CK.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Apr;19(2):537-41. Review. Chinese.

PMID:
21518525
5.

Hepcidin is correlated to soluble hemojuvelin but not to increased GDF15 during pregnancy.

Finkenstedt A, Widschwendter A, Brasse-Lagnel CG, Theurl I, Hubalek M, Dieplinger H, Tselepis C, Ward DG, Vogel W, Zoller H.

Blood Cells Mol Dis. 2012 Apr 15;48(4):233-7. doi: 10.1016/j.bcmd.2012.02.001. Epub 2012 Feb 25.

PMID:
22365732
6.

Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.

Tamary H, Shalev H, Perez-Avraham G, Zoldan M, Levi I, Swinkels DW, Tanno T, Miller JL.

Blood. 2008 Dec 15;112(13):5241-4. doi: 10.1182/blood-2008-06-165738. Epub 2008 Sep 29.

7.

Serum iron metabolism and erythropoiesis in patients with myelodysplastic syndrome not receiving RBC transfusions.

Cui R, Gale RP, Zhu G, Xu Z, Qin T, Zhang Y, Huang G, Li B, Fang L, Zhang H, Pan L, Hu N, Qu S, Xiao Z.

Leuk Res. 2014 May;38(5):545-50. doi: 10.1016/j.leukres.2014.01.016. Epub 2014 Feb 10.

8.

Liver iron concentrations and urinary hepcidin in beta-thalassemia.

Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E.

Haematologica. 2007 May;92(5):583-8.

9.

Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy.

Weiss G, Theurl I, Eder S, Koppelstaetter C, Kurz K, Sonnweber T, Kobold U, Mayer G.

Eur J Clin Invest. 2009 Oct;39(10):883-90. doi: 10.1111/j.1365-2362.2009.02182.x. Epub 2009 Jun 26.

PMID:
19563467
10.

[GDF15 expression and iron overload in ineffective erythropoiesis].

Tanno T, Miller JL.

Rinsho Ketsueki. 2011 Jun;52(6):387-98. Review. No abstract available.

PMID:
21737991
11.

Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection.

Hendy OM, Allam M, Allam A, Attia MH, El Taher S, Eldin MM, Ali A.

Egypt J Immunol. 2010;17(2):33-44.

PMID:
23082485
12.

Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause.

Waalen J, von Löhneysen K, Lee P, Xu X, Friedman JS.

Eur J Haematol. 2011 Aug;87(2):107-16. doi: 10.1111/j.1600-0609.2011.01631.x.

PMID:
21535154
13.

[The effect of tobacco smoking during pregnancy on concentration of pro-hepcidin and some parameters of iron metabolism in matched-maternal cord pairs].

Chełchowska M, Lewandowski L, Ambroszkiewicz J, Swiatek E, Gajewska J, Ołtarzewski M, Laskowska-Klita T.

Przegl Lek. 2008;65(10):474-8. Polish.

PMID:
19189526
14.

Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal study.

Pasricha SR, Frazer DM, Bowden DK, Anderson GJ.

Blood. 2013 Jul 4;122(1):124-33. doi: 10.1182/blood-2012-12-471441. Epub 2013 May 8.

15.

Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation.

Tanno T, Rabel A, Lee YT, Yau YY, Leitman SF, Miller JL.

Transfusion. 2010 Jul;50(7):1532-5. doi: 10.1111/j.1537-2995.2010.02601.x. Epub 2010 Feb 26.

16.

Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.

Przybyłowski P, Wasilewski G, Bachorzewska-Gajewska H, Golabek K, Dobrzycki S, Małyszko J.

Transplant Proc. 2014 Oct;46(8):2852-5. doi: 10.1016/j.transproceed.2014.09.040.

PMID:
25380934
17.

Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.

Fertrin KY, Lanaro C, Franco-Penteado CF, de Albuquerque DM, de Mello MR, Pallis FR, Bezerra MA, Hatzlhofer BL, Olbina G, Saad ST, da Silva Araújo A, Westerman M, Costa FF.

Am J Hematol. 2014 Apr;89(4):385-90.

PMID:
24860871
18.

Regulation of hepcidin expression at high altitude.

Talbot NP, Lakhal S, Smith TG, Privat C, Nickol AH, Rivera-Ch M, León-Velarde F, Dorrington KL, Mole DR, Robbins PA.

Blood. 2012 Jan 19;119(3):857-60. doi: 10.1182/blood-2011-03-341776. Epub 2011 Nov 30.

19.

Hepcidin in trauma: linking injury, inflammation, and anemia.

Sihler KC, Raghavendran K, Westerman M, Ye W, Napolitano LM.

J Trauma. 2010 Oct;69(4):831-7. doi: 10.1097/TA.0b013e3181f066d5.

PMID:
20938270
20.

Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression.

Frazer DM, Wilkins SJ, Darshan D, Badrick AC, McLaren GD, Anderson GJ.

Br J Haematol. 2012 Jun;157(5):615-26. doi: 10.1111/j.1365-2141.2012.09104.x. Epub 2012 Mar 26.

PMID:
22449175
Items per page

Supplemental Content

Write to the Help Desk